Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benznidazole-treated chronic Chagas disease biomarker and echocardiography study
2012-002645-38Phase 4Active
- Sponsor
- CRESIB
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of benznidazole in American trypanosomiasis (CD) (2 arms), sponsored by CRESIB. Primary endpoint: Correlation between molecular factors and echocardiography after antiparasitic treatment. Started Aug 2012; status: active.
02
Drugs
benznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on 2012-002645-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002645-38.